Sublingual Allergen-Specific Immunotherapy Adjuvanted with Monophosphoryl Lipid A: A Phase I/IIa Study

Publisher： Karger

E-ISSN： 1423-0097|154|4|336-344

ISSN： 1018-2438

Source： International Archives of Allergy and Immunology, Vol.154, Iss.4, 2010-10, pp. : 336-344

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Safety of Allergen Specific Sublingual Immunotherapy

By  

Current Drug Safety, Vol. 2, Iss. 2, 2007-05 ,pp. : 117-123

Bentham Science Publishers

Access to resources Recommend Favorite

Immunological Mechanisms Operative in Allergen–Specific Immunotherapy

By  

International Archives of Allergy and Immunology, Vol. 119, Iss. 1, 1999-04 ,pp. : 1-5

Karger

Access to resources Recommend Favorite

Sustained effect of grass pollen subcutaneous immunotherapy on suppression of allergen‐specific basophil response; a real‐life, nonrandomized controlled study

By  

ALLERGY, Vol. 70, Iss. 5, 2015-05 ,pp. : 547-555

John Wiley & Sons Inc

Access to resources Recommend Favorite

Enhancement of the Frequency and Function of IL-10-Secreting Type I T Regulatory Cells after 1 Year of Cluster Allergen-Specific Immunotherapy

By  

International Archives of Allergy and Immunology, Vol. 159, Iss. 4, 2012-07 ,pp. : 391-398

Karger

Access to resources Recommend Favorite

Treatment of Atopic Dermatitis with a Combination of Allergen-Specific Immunotherapy and a Histamine-Immunoglobulin Complex

By  

International Archives of Allergy and Immunology, Vol. 146, Iss. 3, 2008-02 ,pp. : 235-240

Karger

Access to resources Recommend Favorite